Idexx Laboratories CAG — Cost of revenue decreased by 1.9% to $386.54M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 12.0%, from $345.01M to $386.54M. Over 3 years (FY 2022 to FY 2025), CAG — Cost of revenue shows an upward trend with a 6.3% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to revenue suggests rising production costs or supply chain inefficiencies, whereas a decrease relative to revenue indicates improved manufacturing or service delivery margins.
This metric captures the direct costs associated with producing and delivering the diagnostic products and services with...
Comparable to cost of goods sold (COGS) reported by other diagnostic equipment and medical supply manufacturers.
idxx_segment_cag_cost_of_revenue| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $313.05M | $313.05M | $313.05M | $313.05M | $337.48M | $337.48M | $337.48M | $337.48M | $343.05M | $353.23M | $347.53M | $351.06M | $345.01M | $380.34M | $385.08M | $394.18M | $386.54M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +7.8% | +0.0% | +0.0% | +0.0% | +1.6% | +3.0% | -1.6% | +1.0% | -1.7% | +10.2% | +1.2% | +2.4% | -1.9% |
| YoY Change | — | — | — | — | +7.8% | +7.8% | +7.8% | +7.8% | +1.6% | +4.7% | +3.0% | +4.0% | +0.6% | +7.7% | +10.8% | +12.3% | +12.0% |